![]() AB Science AB Science is a pharmaceutical company that engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ![]() Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | |
Founding Date | Founding Date 2001 | Founding Date 1928 | Founding Date 1951 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Paris, FR HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | |
Employees | Employees 40 | Employees 9,052 | Employees 8,5201% increase |
Valuation ($) | Valuation ($) 70.2 m | Valuation ($) 34.3 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €1.2m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €196k (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €978k (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit N/A |
Net income | Net income (€1.6m) (FY, 2025) | Net income €1.6b (FY, 2025) | Net income N/A |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View company